These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 13991740)

  • 1. [The progressive effective inhibitors of blood coagulation following Marcumar poisoning].
    SCHIMPF K
    Klin Wochenschr; 1963 Mar; 41():283-6. PubMed ID: 13991740
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of the administration of the anticoagulant marcumar on the blood coagulation mechanisms.
    CALDWELL MJ; JOHNSON SA; PRIEST EM
    Henry Ford Hosp Med Bull; 1956 Dec; 4(4):224-7. PubMed ID: 13384917
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of oral anticoagulant (marcumar) on prothrombin and related components in blood coagulation.
    JOHNSON SA; CALDWELL MJ; PRIEST EM
    Circ Res; 1957 May; 5(3):252-6. PubMed ID: 13427137
    [No Abstract]   [Full Text] [Related]  

  • 4. [On the therapy of circulatory and coagulation disorders with the anticoagulants Helodym 88 and Marcumar].
    FLACH KH
    Munch Med Wochenschr; 1961 Oct; 103():2031-3. PubMed ID: 13893403
    [No Abstract]   [Full Text] [Related]  

  • 5. [Pharmacokinetic studies in increased reactivity to phenprocoumon (Marcumar)].
    Chriske HW; von Smekal P; Knabe M; Kray D
    Med Welt; 1973 Oct; 24(42):1620-1. PubMed ID: 4764456
    [No Abstract]   [Full Text] [Related]  

  • 6. Proceedings: Binding properties of phenprocoumon (Marcumar) to human blood.
    Niedner R; von Oettingen U; Meyer F
    Naunyn Schmiedebergs Arch Pharmacol; 1975; 287 Suppl():R88. PubMed ID: 1143511
    [No Abstract]   [Full Text] [Related]  

  • 7. [Oral anticoagulation with vitamin K antagonists].
    Alberio L
    Ther Umsch; 2003 Jan; 60(1):5-9. PubMed ID: 12638470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of allopurinol with phenprocoumon in man.
    Jähnchen E; Meinertz I; Gilfrich HJ
    Klin Wochenschr; 1977 Aug; 55(15):759-61. PubMed ID: 895010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Peculiarities in the treatment of dialysis patients using phenprocoumon (Marcumar)].
    Held H; Baetzner P; Liebau G; Bundschu HD; Hayduk K
    Verh Dtsch Ges Inn Med; 1975; 81():1013-5. PubMed ID: 1229387
    [No Abstract]   [Full Text] [Related]  

  • 10. [On the use of Marcumar and Dicumarol in long-term treatment. (Comparative studies)].
    CLAUSEN J; ANDRESEN P; GRUELUND S; HARSLOF E; ANDERSEN UH; JORGENSEN J; MOSE C
    Thromb Diath Haemorrh; 1961 Jul; 6():37-44. PubMed ID: 13693954
    [No Abstract]   [Full Text] [Related]  

  • 11. Dicumarol, coumadin, marcumar and tromexan; comparative study of their action on the clot as registered by the thrombelastogram.
    ESCUDERO J; McDEVITT E; WRIGHT IS
    Circulation; 1959 Sep; 20():405-12. PubMed ID: 13820773
    [No Abstract]   [Full Text] [Related]  

  • 12. [Case report. Phenprocoumon (Marcumar, Falithrom) as an unusual reason for coumarin poisoning in a dog].
    Lutze G; Römhild W; Elwert J; Leppelt J; Kutschmann K
    Dtsch Tierarztl Wochenschr; 2003 Jan; 110(1):31-3. PubMed ID: 12596669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of phenprocoumon in man investigated using a gas chromatographic method of drug analysis.
    Heni N; Glogner P
    Naunyn Schmiedebergs Arch Pharmacol; 1976 May; 293(2):183-6. PubMed ID: 958506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Results of general thromboembolism prophylaxis with marcumar after major gynecological operations].
    SOERGEL W
    Zentralbl Gynakol; 1960 Jan; 82():28-35. PubMed ID: 13832444
    [No Abstract]   [Full Text] [Related]  

  • 15. [Elimination kinetics of phenprocoumon (Marcumar) in liver cirrhosis and after premedication with phenobarbital].
    Heni N; Lehnhardt G; Glogner P
    Int J Clin Pharmacol Biopharm; 1976 Jun; 13(4):253-61. PubMed ID: 965132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Tromexan and marcoumar in anticoagulant therapy; micromethod for determination of prothrombin-proconvertin activity].
    IVERSEN T
    Ugeskr Laeger; 1955 Jul; 117(27):873-8. PubMed ID: 13256759
    [No Abstract]   [Full Text] [Related]  

  • 17. Experience with the anticoagulant, marcumar.
    ENSOR RE; PETERS HR
    Ann Intern Med; 1957 Oct; 47(4):731-43. PubMed ID: 13470699
    [No Abstract]   [Full Text] [Related]  

  • 18. Marcumar, a new anticoagulant.
    BOURGAIN R; WRIGHT IS
    Rev Hematol; 1955; 10(2):387-9; discussion, 412-22. PubMed ID: 13255434
    [No Abstract]   [Full Text] [Related]  

  • 19. [Marcumar, 3-1-phenylpropyl-4-oxy-coumarin, a new superdicumarol].
    MATIS P
    Arztl Forsch; 1953 Jun; 7(6):I/298-302. PubMed ID: 13091939
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of 3-(1-phenylpropyl)-4-hydroxycoumarin (marcumar) on the functional, morphological and histochemical characteristics of blood platelets and megakaryocytes; experimental research].
    SALVI F; RICCI M
    Haematologica; 1955; 39(6):425-40. PubMed ID: 13262650
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.